FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.
Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
The Ozempic Shortage Is Over
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
Investopedia9h
Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply
U.S. Food & Drug Administration. “Declaratory Order: Resolution of Shortages of Semaglutide Injection Products (Ozempic and Wegovy).” U.S. Food & Drug Administration. “FDA Clarifies Policies for ...
Bureau of Meteorology5h
128 km Cairns Radar Loop
This page contains programming that requires a scriptable browser. If you have disabled="true" scripting in your browser then you may wish to enable it so that the ...